Reproterol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number | 54063-54-6 |
| ATC code | R03AC15 |
| PubChem | CID: 25654 |
| ChemSpider | 23898 |
| UNII | 11941YC6RN |
| KEGG | D08474 |
| ChEMBL | CHEMBL1095607 |
| Chemical data | |
| Formula | C18H23N5O5 |
| Molecular mass | 389.406 g/mol |
|
|
|
|
| |
Reproterol (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]
References[edit]
- ^ Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both? Respiration. 1999;66(3):210-1. PMID 10364735
|
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |

